Jim Foote explains why cancer treatment still relies on tradition more than biology, and how functional testing of a patient’s own tumor can change that.
We unpack his decision support approach that ranks drugs and combinations by sensitivity, the clinical evidence and validation behind it, and the practical realities of getting results into oncologists’ hands when time, toxicity, and payer rules all collide.
